Microwave Ablation Feasible for T1N0M0 Papillary Thyroid Carcinoma
FRIDAY, April 12, 2024 -- For patients with multifocal papillary thyroid carcinoma (PTC), the rates of progression-free survival (PFS) do not differ between microwave ablation (MWA) and surgical resection (SR), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2024 Category: Pharmaceuticals Source Type: news
GLP-1 Receptor Agonists Don't Raise Thyroid Cancer Risk GLP-1 Receptor Agonists Don't Raise Thyroid Cancer Risk
A cohort study in three Scandinavian countries found no significant increase in thyroid cancer risk with glucagon-like peptide 1 receptor agonists.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 12, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news
Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists
(MedPage Today) -- A Scandinavian cohort study suggested a popular class of diabetes drug did not put patients at an elevated risk for thyroid cancer, a longtime lingering concern with this drug class.
Compared with DPP-4 inhibitors, patients... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - April 10, 2024 Category: Urology & Nephrology Source Type: news
Taylor Swift Is Embracing the 5 Stages of Grief. Should You?
Call it the Five Stages of Grief (Taylor’s Version). Last week, ahead of the release of her album The Tortured Poets Department, Taylor Swift shared five new playlists that sort her old songs into stages: denial, anger, bargaining, depression, and acceptance. “These songs represent making room for more good in your life,” she says in a brief audio message accompanying the final playlist, acceptance. “Making that choice. Because a lot of time when we lose things, we gain things too.”
[time-brightcove not-tgx=”true”]
In the two months since Swift announced her new album, which co...
Source: TIME: Health - April 10, 2024 Category: Consumer Health News Authors: Angela Haupt Tags: Uncategorized Evergreen healthscienceclimate Source Type: news
Ozempic, Wegovy Won't Boost Thyroid Cancer Risk: Study
WEDNESDAY, April 10, 2024 -- Wegovy, Ozempic and other drugs known as GLP-1 analogues have become wildly popular for controlling diabetes and helping folks lose weight.
There were concerns that longer term use of the drugs might raise users ' odds... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 10, 2024 Category: General Medicine Source Type: news
UltraCon: Microflow imaging on par with CEUS for guiding tumor ablation
AUSTIN -- Microflow imaging performs just as well as contrast-enhanced ultrasound (CEUS) for guiding tumor ablation and may be an economical alternative, according to research presented April 8 at UltraCon.
In her talk, Ziyue Hu, MD, from Sichuan Cancer Hospital in China highlighted findings showing that along with yielding comparable performance in treating thyroid nodules, microflow imaging in this area is less costly and invasive than CEUS.
“We found that in the microwave ablation procedure for thyroid nodules that … microflow imaging offers the advantages of reducing surgical expenses, which lessens the economic ...
Source: AuntMinnie.com Headlines - April 9, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
Unleashing CAR-T cell therapy to destroy solid tumors in thyroid cancer
Mayo Clinic researchers will jump four hurdles to apply chimeric antigen receptor-T cell therapy (CAR-T cell therapy) to solid tumors in thyroid cancer. This regenerative immunotherapy has shown promising results in blood cancers, and new research is focused on using this treatment on more types of malignancies. "CAR-T cell therapy is unlike other therapeutics," says Saad Kenderian, M.B., Ch.B., a hematologist and cancer researcher. "Other therapies may slow down cancer. CAR-T cell therapy has shown… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 9, 2024 Category: Databases & Libraries Source Type: news
The rise of theranostics: Part 2 -- Moving into communities
A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. That has changed and the field of theranostics is expanding rapidly in various ways, as described in part 1 of AuntMinnie.com's series on the rise of theranostics.
However, few freestanding theranostics centers exist today. Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. They're also mindful of the multiple dedicated teams required to build a thera...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: Liz Carey Tags: Practice Management Radiation Oncology/Therapy Nuclear Medicine Medicolegal Genitourinary Radiology Source Type: news
Microwave Treatment Could Be an Advance Against Thyroid Tumors
WEDNESDAY, April 3, 2024 -- Microwaves could offer an alternative to surgery for some people with thyroid cancer, a new study suggests.Microwave ablation, which uses heat to destroy tumors, more effectively targeted thyroid cancers on multiple... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 3, 2024 Category: General Medicine Source Type: news
Microwave Ablation a Safer Option for Multifocal Papillary Thyroid Carcinoma?
(MedPage Today) -- The use of microwave ablation to treat ultrasound-detected, multifocal papillary thyroid carcinoma (PTC) was associated with the same outcomes but fewer complications compared with surgical resection, according to results from... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - April 2, 2024 Category: Radiology Source Type: news
Microwave ablation on par with surgery for thyroid cancer survival
Microwave ablation may be a suitable alternative to surgical resection when it comes to ultrasound-detected thyroid cancer, a study published April 2 in Radiology found.
Researchers led by Zhen-Long Zhao, MD, from China-Japan Friendship Hospital in Beijing found no significant difference in progression-free survival rates between patients receiving ablation or surgery. Additionally, microwave ablation led to less blood loss, shorter incision length, and shorter procedure and hospitalization durations.
“Microwave ablation is a feasible option for selected patients with multifocal T1N0M0 papillary thyroid carcinoma,” Z...
Source: AuntMinnie.com Headlines - April 2, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
The rise of theranostics: Part 1 -- Gaining momentum
Since the U.S. Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research.Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After the therapeutic agent binds to the cancer cells, the tumors are treated in such a way that aims to prevent collateral damage to healthy cells and improve overall outcomes.Theranostics isn’t new; nuclear medicine d...
Source: AuntMinnie.com Headlines - March 26, 2024 Category: Radiology Authors: Liz Carey Tags: Practice Management Molecular Imaging Radiation Oncology/Therapy Nuclear Medicine Source Type: news
How to survive cancer, from the man who has beaten the disease five times
Bill Potts from Florida has survived cancer five times: thyroid cancer once and non-Hodgkin lymphoma four times. 'It sounds odd to even say those words. It's such a big number,' he said. (Source: the Mail online | Health)
Source: the Mail online | Health - March 24, 2024 Category: Consumer Health News Source Type: news
Ozempic Gets the Oprah Treatment in a New TV Special
Weight-loss drugs like Ozempic, Wegovy, and Zepbound are already extremely popular: by 2030, about 10% of the U.S. population will be on one of these drugs and the category’s sales will surpass $100 billion, according to some projections. On March 18, they got another major cultural boost from Oprah Winfrey, who shared her own experience with—and support for—these medications in an ABC special called “Shame, Blame and the Weight Loss Revolution.”
[time-brightcove not-tgx=”true”]
During the special, Winfrey talked about how using one of these weight-loss drugs (she did not say w...
Source: TIME: Health - March 19, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
Wegovy Is Good for More Than Just Weight Loss
The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It’s the first weight-loss drug to carry an indication for heart benefits.
The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo.
[time-brightcove not-tgx=...
Source: TIME: Health - March 8, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
